Clinical Trial Update: A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BL-B01D1 vs investigator's choice chemotherapy in platinum-resistant recurrent epithelial ovarian cancer and related cancers; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• BL-B01D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: RECRUITING